View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
VA | RIN: 2900-AQ31 | Publication ID: Spring 2018 |
Title: ●Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists | |
Abstract:
The Department of Veterans Affairs (VA) is amending its medical regulations that govern copayments to conform with recent statutory requirements. VA is eliminating the copayment requirement for veterans at high risk of suicide who are prescribed opioid antagonists. VA is also clarifying that no copayment will be required for the provision of education on the use of opioid antagonists. This final rule is an essential part of VA’s attempts to help veterans at risk of suicide. |
|
Agency: Department of Veterans Affairs(VA) | Priority: Substantive, Nonsignificant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
EO 13771 Designation: Other | |
CFR Citation: 38 CFR 17.108 38 CFR 17.110 | |
Legal Authority: Pub. L. 114-198, sec. 915 Pub. L. 114-223, sec. 243 |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Sandra Mize Program Analyst (CBO FO) Department of Veterans Affairs 3773 Cherry Creek North Drive, Denver, CO 80209 Phone:303 331-7545 Email: sandra.mize@va.gov |